Transient congenital hypothyroidism due to maternal intake of antithyroid drugs (Q86199): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/809146001 / rank | |||
Normal rank | |||
Revision as of 11:33, 15 August 2026
Transient congenital hypothyroidism can develop in a fetus and newborn if their mother is being treated with antithyroid drugs, such as, carbimazole, methimazole (MMI), or propylthiouracil (PTU), for the treatment of Graves disease. Transient symptoms include an enlarged thyroid gland and respiratory problems. The hypothyroidism, goitre, and associated symptoms resolve once the drug has been cleared from the circulation.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_809146001 |
||
| English | Transient congenital hypothyroidism due to maternal intake of antithyroid drugs |
Transient congenital hypothyroidism can develop in a fetus and newborn if their mother is being treated with antithyroid drugs, such as, carbimazole, methimazole (MMI), or propylthiouracil (PTU), for the treatment of Graves disease. Transient symptoms include an enlarged thyroid gland and respiratory problems. The hypothyroidism, goitre, and associated symptoms resolve once the drug has been cleared from the circulation. |
